Pyxis Oncology Inc (PYXS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PYXS | NBTX | PROC | ||
| Company | Pyxis Oncology Inc | Nanobiotix S.A. ADR | Procaps Group S.A. | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 3.70 | 5.03 | 1.8500 | ||
| High | 3.83 | 5.04 | 1.9000 | ||
| Low | 3.65 | 4.86 | 1.8000 | ||
| Last | 3.78 | 4.95 | 1.8500 | ||
| Change | +0.14 | -0.12 | +0.0100 | ||
| % Change | +3.85% | -2.37% | +0.54% | ||
| Volume | 437,100 | 8,500 | 10,300 | ||
| 20-Day Average Volume | 332,595 | 8,750 | 5,140 | ||
| Previous Close | 3.64 | 5.07 | 1.8400 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 3.63 | 5.21 | 1.9381 | ||
| 20-Day Raw Stochastic | 81.67% | 19.23% | 12.82% | ||
| 20-Day Relative Strength | 54.43% | 45.67% | 38.34% | ||
| Weighted Alpha | +5.53 | -44.12 | -52.04 | ||
| Today's Opinion | 8% Sell | 88% Sell | 100% Sell | ||
| Previous Opinion | 40% Sell | 88% Sell | 100% Sell | ||
| Last Month's Opinion | 48% Sell | 100% Sell | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +8.00% since 09/06/24 | -6.60% since 09/06/24 | +0.54% since 09/05/24 | ||
| Low | 3.48 on 09/09/24 | 4.86 on 09/13/24 | 1.8000 on 09/13/24 | ||
| High | 3.89 on 09/10/24 | 5.67 on 09/09/24 | 2.0200 on 09/11/24 | ||
| 1-Month | |||||
| %Chg | +8.93% since 08/13/24 | +2.91% since 08/13/24 | -3.65% since 08/13/24 | ||
| Low | 3.24 on 08/14/24 | 4.60 on 08/15/24 | 1.8000 on 09/13/24 | ||
| High | 3.89 on 09/10/24 | 6.00 on 08/30/24 | 2.1900 on 08/23/24 | ||
| 3-Month | |||||
| %Chg | -4.30% since 06/13/24 | -7.48% since 06/13/24 | -28.02% since 06/13/24 | ||
| Low | 2.81 on 07/09/24 | 4.14 on 06/24/24 | 1.8000 on 09/13/24 | ||
| High | 4.13 on 07/24/24 | 6.00 on 08/30/24 | 2.8800 on 06/24/24 | ||
| 6-Month | |||||
| %Chg | -29.35% since 03/13/24 | -22.05% since 03/13/24 | -41.21% since 03/13/24 | ||
| Low | 2.81 on 07/09/24 | 4.14 on 06/24/24 | 1.8000 on 09/13/24 | ||
| High | 6.18 on 04/03/24 | 7.51 on 05/16/24 | 3.3800 on 05/03/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 222,597 | 233,308 | 208,717 | ||
| Shares Outstanding, K | 58,888 | 47,133 | 112,820 | ||
| Annual Sales | 0 | 39,190,000 | 409,920,000 | ||
| Annual Net Income | -73,790,000 | -42,970,000 | 42,540,000 | ||
| Last Quarter Sales | 16,150,000 | N/A | 118,410,000 | ||
| Last Quarter Net Income | -3,260,000 | N/A | 8,190,000 | ||
| 60-Month Beta | 1.28 | 0.27 | 0.15 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.29 on 08/14/24 | N/A | 0.08 on 12/26/23 | ||
| Latest Earnings Date | 11/05/24 | 05/22/24 | 09/17/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 3.54 | ||